Publications | My Site 4

Under revision

Doeser MC, Krygin J, Röpke A, Han D, Wedlich-Söldner R, f, Schöler HR, Pavenstädt H, Kim KP. Generation of a human iPSC line (MPIi008-A) from a patient with Denys-Drash syndrome. Stem Cell Research (Impact factor: 2.02)

Han D, Jeong HW, Hemmer K, Tsytsyura Y, Wu G, Kim KP, Renner H, Han DW, Gerovska D, Arauzo-Bravo MJ, Klingauf J, Schwamborn JC, Adams R, Schöler HR. Multipotent neural stem cells with unique molecular feature exist out of mouse central nervous system. Cell Stem Cell. (Impact factor: 20.860).

Sathyanarayanan A, Ing-Simmons L, Ozguldez HO, Kim KP, Kim YS, Stehling M, Brinkmann H, Schöler HR, Vaquerizas JM, Bedzhov I. XEN state reprogramming into self-organizing trophectoderm-like cells enables the assembly of synthetic embryoids. Nature communications. (Impact factor: 12.121).

Published

(2022)

Han D, Wu G, Drexler HCA, MacCarthy C, Kim KP, Adachi K, Gerovska D, Arauzo-Bravo MJ, Schöler HR. A balanced Oct4 interactome is crucial for maintaining pluripontecy. Science Advances. Sci Adv. 2022 Feb 18;8(7):eabe4375. (Impact factor: 13.116).

(2021)

35. Chen Y, Luttmann FF, Schoger E, Scholer H, Zelarayan LC, Kim KP, Haigh J, Kim J, Braun T. Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice. Science. 2021 Sep 24;373(6562):1537-1540 (Impact factor: 41.845). 바로가기

Commented by Wang YX, Blau HM.Wang YX, et al. Reversing aging for heart repair. Science. 2021 Sep 24;373(6562):1439-1440. 바로가기

34. Guo H, Jin ZL, Yao X, Park J, Gwon YP, Kim S, Kim KP, Cui XS, Kim NH, Yoo H, Han DW. Derivation of iPSC lines from two idiopathic ASD patients (OFi001-A, OFi002-A). Stem Cell Res. 2021 Aug 19;56:102510 (Impact factor: 4.489). 바로가기

33. Kim KP, Han D, Kim J, Schöler HR. Biological importance of Oct factors in reprogramming and development. Exp Mol Med. 2021 Jun;53(6):1018-1028 (Impact factor: 5.958). 바로가기

32. Kim KP, Li C, Bunina D, Jeong HW, Ghelman J, Kwak TH, Yoon JY, Shin B, Park H, Han DW, Zaugg JB, Kuhlmann T, Kim J, Adams RH, Goldman SA, Schöler HR. Donor-cell memory and transgene-mediated off-targets endow metastable state to directly converted cells. Cell Stem Cell. (Impact factor: 20.860). 바로가기

31. Chanoumidou K, Hernández-Rodríguez B, Windener F, Thomas C, Stehling M, Mozafari S, Ottoboni L, Antel J, Kim KP, Velychko S, Cui QL, Martino G, Winkler J, Schöler HR, Evercooren AB, Boespflug-Tanguy O, Vaquerizas JM, Ehrlich M, Kuhlmann1 T. One-step reprogramming of human fibroblasts into oligodendrocytes by SOX10, OLIG2 and NKX6.2. Stem Cell Reports. 2021 Apr 13;16(4):771-783. (Impact factor: 6.032) 바로가기

(2020)

30. Mozafari S, Starost L, Manot-Saillet B, Garcia-Diaz B, Xu YKT, Roussel D, Levy MJF, Ottoboni L, Kim KP, Schöler HR, Kennedy TE, Antel JP, Martino G, Angulo MC, Kuhlmann T, Evercooren AB. Multiple sclerosis iPSC-derived oligodendrocytes conserve their intrinsic properties to functionally interact with axons and glial cells in vivo. Science Adv. 2020 Dec 4;6(49):eabc6983. (Impact factor: 13.116) 바로가기

29. Kim KP, Yoon J, Kim J, Röpke A, Shin B, Han DW, Greber B, Schöler HR. Generation of a human iPSC line (MPIi007-A) from a patient with Metachromatic leukodystrophy Stem Cell Res. 2020 Oct;48:101993 (Impact factor: 4.489) 바로가기

28. Kim KP, Wu Y, Yoon J, Adachi K, Wu G, Velychko S, MacCarthy CM, Shin B, Röpke A, Arauzo-Bravo MJ, Stehling M, Han DW, Gao Y, Kim J, Gao S, Schöler HR. Reprogramming competence of OCT factors is determined by transactivation domains. Sci Adv. 2020 Sep 02 DOI: 10.1126/sciadv.aaz7364 (Impact factor: 13.116) 바로가기

27. Kim KP, Choi J, Yoon J, Bruder JM, Shin B, Kim J, Arauzo-Bravo MJ, Han D, Wu G, Han DW, Kim J, Cramer P, Schöler HR. Permissive epigenomes endow reprogramming competence to transcriptional regulators. Nat Chem Biol. 2020 Aug 17. (Impact factor: 12.587). 바로가기

- Highlighted by Raas MWD., Zijlmans DW, Marks H. Overcoming epigenetic roadblocks. Nat Chem Biol. 2020 Aug 17. 바로가기

26. Kim KP, Yoon J, Shin B, Röpke A, Han DW, Schöler HR. Generation of a human iPSC line (MPIi006-A) from a patient with Pelizaeus-Merzbacher disease. Stem Cell Res. 2020 Jul;46:101839. (Impact factor: 4.489) 바로가기

25. Kwak TH, Kang JH, Hali S, Kim J, Kim KP, Park C, Lee JH, Ryu HK, Na JE, Jo J, Je HS, Ng HH, Kwon J, Kim NH, Hong KH, Sun W, Chung CH, Rhyu IJ, Han DW. Generation of homogenous midbrain organoids with in vivo-like cellular composition facilitates neurotoxin-based parkinson’s disease modeling. Stem Cells. 2020 Jun. (Impact factor: 6.022) 바로가기

24. Kwak TH, Hali S, Kim S, Kim J, La H, Kim KP, Hong KH, Shin CY, Kim NH, Han DW. Robust and reproducible generation of induced neural stem cells from human somatic cells by defined factors.

Int J Stem Cells. 2020 Mar 30;13(1):80-92. (Impact factor: 1.940) 바로가기

(2019)
23. Velychko S, Adachi K, Kim KP, Hou Y, MacCarthy CM, Wu G, Schöler HR. Excluding Oct4 from yamanaka cocktail unleashes the developmental potential of iPSCs. Cell Stem Cell. 2019 Dec 5;25(6):737-753.e4. (Impact factor: 20.860) 바로가기

22. Park H, Yamamoto H, Mohn L, Ambühl L, Kanai K, Schmidt I, Kim KP, Fraccaroli A, Feil S, Junge HJ, Montanez E, Berger W, Adams RH. Integrin-linked kinase controls retinal angiogenesis and is linked to Wnt signaling and exudative vitreoretinopathy. Nat Commun. 2019 Nov 20;10(1):5243. (Impact factor: 12.121) 바로가기

21. Hwang SI, Kwak TH, Kim JH, JH Kang, Lee HS, Kim KP, Ko KN, Schöler HR. Han DW. Metastable reprogramming state of single transcription factor–derived induced hepatocyte-like cells. Stem Cells Int. 2019 Apr 7;2019:6937257 (Impact factor: 3.869) 바로가기

20. Velychko S, Kang K, Kim SM, Kwak TH, Kim KP, Park CH, Hong KH, Chung CH, Hyun JK, MacCarthy CM, Wu G, Schöler HR. Han DW. Fusion of reprogramming factors alters trajectory of somatic lineage conversion. Cell Rep. 2019 Apr 2;27(1):30-39.e4. (Impact factor: 8.109) 바로가기

(2018)

19. Lim KT, Kim J, Hwang SI, Zhang L, Han H, Bae D, Kim KP, Hu YP, Schöler HR, Lee I, Hui L, Han DW. Direct conversion of mouse fibroblasts into cholangiocyte progenitor cells. Stem Cell Reports. 2018 May 8;10(5):1522-1536. (Impact factor: 6.032) 바로가기

18. Im JH, Hwang SI, KIM JW, Park SJ, Kang KR, You JS, Kim KP, Moon SH, Cha HJ, Chung HM, Schöler HR, Hyun JK, Han DW. Inhibition of BET selectively eliminates undifferentiated pluripotent stem cells. Science Bulletin. 2018 Mar volume 63, issue 8: 477-487 (Impact factor: 9.511) 바로가기

(2017)

17. Jeong HW, Hernández-Rodríguez B, Kim J, Kim KP, Enriquez-Gasca R, Yoon J, Adams S, Schöler HR, Vaquerizas JM, Adams RH. Transcriptional regulation of endothelial cell behavior during sprouting angiogenesis. Nat Commun. 2017 Sep 28;8(1):726. (Impact factor: 12.121) 바로가기

16. Ehrlich M, Mozafari S, Glatza M, Starost L, Velychko S, Hallmann AL, Cui QL, Schambach A, Kim KP, Bachelin C, Marteyn A, Hargus G, Johnson RM, Antel J, Sterneckert J, Zaehres H, Schöler HR, Baron-Van Evercooren A, Kuhlmann T. Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors. Proc Natl Acad Sci U S A. 2017 Mar 14;114(11):E2243-E2252. (Impact factor: 9.412) 바로가기

15. Jerabek S, Ng CK, Wu G, Arauzo-Bravo MJ, Kim KP, Esch D, Malik V, Chen Y, Velychko S, MacCarthy CM, Yang X, Cojocaru V, Schöler HR, Jauch R. Changing POU dimerization preferences converts Oct6 into a pluripotency inducer. EMBO Rep. 2017 Feb;18(2):319-333. (Impact factor: 7.497) 바로가기

(2016)

14. Kim SM, Kim JW, Kwak TH, Park SW, Kim KP, Park H, Lim KT, Kang K, Kim J, Yang JH, Han H, Lee I, Hyun JK, Bae YM, Schöler HR, Lee HT, Han DW. Generation of Integration-free Induced Neural Stem Cells from Mouse Fibroblasts. J Biol Chem. 2016 Jul 1;291(27):14199-212. (Impact factor: 4.238) 바로가기

13. Lim KT, Lee SC, Gao Y, Kim KP, Song G, An SY, Adachi K, Jang YJ, Kim J, Oh KJ, Kwak TH, Hwang SI, You JS, Ko K, Koo SH, Sharma AD, Kim JH, Hui L, Cantz T, Schöler HR, Han DW. Small Molecules Facilitate Single Factor-Mediated Hepatic Reprogramming. Cell Rep. 2016 Apr 26;15(4):814-829. (Impact factor: 8.109) 바로가기

12. Illich DJ, Zhang M, Ursu A, Osorno R, Kim KP, Yoon J, Araúzo-Bravo MJ, Wu G, Esch D, Sabour D, Colby D, Grassme KS, Chen J, Greber B, Höing S, Herzog W, Ziegler S, Chambers I, Gao S, Waldmann H, Schöler HR. Distinct Signaling Requirements for the Establishment of ESC Pluripotency in Late-Stage EpiSCs. Cell Rep. 2016 Apr 26;15(4):787-800. (Impact factor: 8.109) 바로가기

11. Kim SM, Lim KT, Kwak TH, Lee SC, Im JH, Hali S, In Hwang S, Kim D, Hwang J, Kim KP, Chung HJ, Kim JB, Ko K, Chung HM, Lee HT, Schöler HR, Han DW. Induced neural stem cells from distinct genetic backgrounds exhibit different reprogramming status. Stem Cell Res. 2016 Mar;16(2):460-8. (Impact factor: 4.489) 바로가기

(2015)

10. Kim J*, Kim KP*, Lim KT, Lee SC, Yoon J, Song G, Hwang SI, Schöler HR, Cantz T, Han DW. Generation of integration-free induced hepatocyte-like cells from mouse fibroblasts. Sci Rep. 2015 Oct 27;5:15706. (Impact factor: 3.998) (*co-first author) 바로가기

9. Zhang M, Schulte JS, Heinick A, Piccini I, Rao J, Quaranta R, Zeuschner D, Malan D, Kim KP, Röpke A, Sasse P, Araúzo-Bravo M, Seebohm G, Schöler H, Fabritz L, Kirchhof P, Müller FU, Greber B. Universal cardiac induction of human pluripotent stem cells in two and three-dimensional formats: implications for in vitro maturation. Stem Cells. 2015 May;33(5):1456-69. (Impact factor: 6.022) 바로가기

8. Sugawa F, Araúzo-Bravo MJ, Yoon J, Kim KP, Aramaki S, Wu G, Stehling M, Psathaki OE, Hübner K, Schöler HR. Human primordial germ cell commitment in vitro associates with a unique PRDM14 expression profile. EMBO J. 2015 Apr 15;34(8):1009-24. (Impact factor: 9.889) 바로가기

(2014)

7. Huang K, Wu Z, Liu Z, Hu G, Yu J, Chang KH, Kim KP, Le T, Faull KF, Rao N, Gennery A, Xue Z, Wang CY, Pellegrini M, Fan G. Selective demethylation and altered gene expression are associated with ICF syndrome in human-induced pluripotent stem cells and mesenchymal stem cells. Hum Mol Genet. 2014 Dec 15;23(24):6448-57. (Impact factor: 5.100) 바로가기

6. Hong JY, Lee SH, Lee SC, Kim JW, Kim KP, Kim SM, Tapia N, Lim KT, Kim J, Ahn HS, Ko K, Shin CY, Lee HT, Schöler HR, Hyun JK, Han DW. Therapeutic potential of induced neural stem cells for spinal cord injury. J Biol Chem. 2014 Nov 21;289(47):32512-25. (Impact factor: 4.238) 바로가기

5. Hargus G, Ehrlich M, Araúzo-Bravo MJ, Hemmer K, Hallmann AL, Reinhardt P, Kim KP, Adachi K, Santourlidis S, Ghanjati F, Fauser M, Ossig C, Storch A, Kim JB, Schwamborn JC, Sterneckert J, Schöler HR, Kuhlmann T, Zaehres H. Origin-dependent neural cell identities in differentiated human iPSCs in vitro and after transplantation into the mouse brain. Cell Rep. 2014 Sep 25;8(6):1697-1703. (Impact factor: 8.109)

바로가기

4. Kim KP, Schöler HR. CellNet--where your cells are standing. Cell. 2014 Aug 14;158(4):699-701. doi: 10.1016/j.cell.2014.08.001. (Impact factor: 38.637) 바로가기

(2013)

3. Han DW, Tapia N, Araúzo-Bravo MJ, Lim KT, Kim KP, Ko K, Lee HT, Schöler HR. Sox2 Level Is a Determinant of Cellular Reprogramming Potential. PLoS One. 2013 Jun 18;8(6):e67594. (Impact factor: 2.740) 바로가기

(2011)

2. Le T*, Kim KP*, Fan G, Faull KF. A sensitive mass spectrometry method for simultaneous quantification of DNA methylation and hydroxymethylation levels in biological samples. Anal Biochem. 2011 May 15;412(2):203-9. (Impact factor: 2.877) (*co-first author) 바로가기

(2007)

1. Kim KP, Thurston A, Mummery C, Ward-van Oostwaard D, Priddle H, Allegrucci C, Denning C, Young L. Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines. Genome Res. 2007 Dec;17(12):1731-42. Epub 2007 Nov 7. (Impact factor: 11.093) 바로가기